HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
95.8%
Total 13F principal
$377,098,000
Principal change
+$633,408
Total reported market value
$361,615,000
Number of holders
30
Value change
+$880,601
Number of buys
12
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q2 2018

As of 30 Jun 2018, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 30 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $377,098,000 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), OAKTREE CAPITAL MANAGEMENT LP, Linden Advisors LP, Allianz Asset Management GmbH, CANYON CAPITAL ADVISORS LLC, PRUDENTIAL PLC, ADVENT CAPITAL MANAGEMENT /DE/, Lion Point Capital, LP, STATE STREET CORP, and Invesco Ltd.. This page lists 30 institutional bondholders reporting positions for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.